Annals of Surgery · 2001 · 22 citations · 46 references
MedicineGeneticsOncologyMetastasisNeoplasiaTumor ProgressionCancer Genomic InstabilityCancer ProgressionColorectal CancerMalignant NeoplasmsMolecular Classification Of TumorsColorectal Liver MetastasisLocal Disease ProgressionLocal Tumor ProgressionMicrosatellite Instability AnalysisMicrosatellite Instability ClassificationMicrosatellite Instability In Colorectal CancerMicrosatellite MarkersMicrosatellite Typing
OBJECTIVE: To investigate the relationship between number and location of allelic imbalances (AI) and local tumor progression according to Astler-Coller classification. SUMMARY BACKGROUND DATA: Spontaneous errors in DNA replication (i.e., allelic imbalance or microsatellite instability) have been suggested to play an important role in carcinomatous transformation as reflecting alterations of gene function. METHODS: One hundred two consecutive patients with colorectal carcinoma undergoing surgical resection were included in this study. Patients were distributed according to the Astler-Coller classification as stages A (n = 7), B1 (n = 15), B2 (n = 24), C (n = 31), and D (n = 25). Fluorescent polymerase chain reaction was performed on frozen tumor, normal colon mucosa, and blood DNA at 35 microsatellite markers. Allelic imbalance frequency was compared with tumor staging. RESULTS: The percentage of AI was significantly higher in stage D than in A/B1 and B2. In addition, the percentage of AI was significantly higher in 10 synchronous colorectal liver metastases than in stage A/B1 and B2 tumors. However, the allelotyping revealed a subgroup of A/B1 tumors with a high AI frequency. Statistical analysis showed that the presence of AI at microsatellites D1S305, D2S138, D3S1282, D17S790, and D22S928 presented a significantly positive correlation with stages. CONCLUSION: The frequency of AI significantly correlates with tumor progression of colorectal cancer. Primary tumors with synchronous colorectal liver metastases showed a higher percentage of AI, suggesting that a frequency of AI greater than 35% with this selection of markers indicates a high risk of local progression and of development of metastases.
46
C. Richard Boland, Stephen N. Thibodeau, Stanley R. Hamilton et al. · PubMed · 1998 · 4.1K citations
Life Sciences, Genetics, Oncology +17
Paul Polakis · Genes & Development · 2000 · 3.2K citations · Full text
Yadong Wang, Wei Wang, Chuan Shen et al. · Hepatogastroenterology · 2012 · 1.6K citations
Tissue inhibitors of metalloproteinases: structure, regulation and biological functions.
Daniel E. Gómez, Daniel F. Alonso, Hitoshi Yoshiji et al. · PubMed · 1997 · 1.5K citations